1. Gubentongluo decoction alleviates NLRP3 inflammasome in IgAN cell model
- Author
-
Wei Meng, Jiao-Jiao Shen, Ting-Yu Liang, Qing Wu, Luo-Bing Wang, Di Huang, Fei-Peng Xu, Jia-Yuan Bai, Xue-Jun Yang, and Pei-Cheng Shen
- Subjects
igan ,nlrp3 ,gubentongluo ,il-1β ,Biotechnology ,TP248.13-248.65 ,Life ,QH501-531 - Abstract
Immunoglobulin A nephropathy (IgAN), the most common primary renal disease, is characterized by abnormal IgA1 deposition. IgAN is caused by NOD-like receptor pyrin domain-containing-3 (NLRP3), which regulates innate immunity. Gubentongluo (GB) decoction, a traditional Chinese medicine, is an effective clinical treatment for IgAN in China. However, little is known about the underlying mechanisms. In this study, IgA1, which is separated from patients with IgAN, together with GB decoction was applied to treat human mesangial cells (HMCs). CCK-8 and the enzyme-linked immunosorbent assay were used to assess cell proliferation and the production of interleukin-1β (IL-1β), respectively. qPCR and Western blot were applied to detect the expression levels of NLRP3, IL-1β, and caspase-1. Our results showed that GB decoction inhibited IgA1-induced cell proliferation and IL-1β production. Furthermore, IgA1-induced upregulation of IL-1β, NLRP3, and caspase-1 was reduced after treatment with GB. Interestingly, MCC950, an NLRP3 inhibitor, showed similar effect as GB decoction. Additionally, NLRP3 overexpression stimulated cell proliferation, IL-1β secretion, and the expressions of IL-1β and caspase-1 in HMCs. But these effects could be alleviated by GB decoction. In conclusion, GB may play a protective role in IgAN cell model by inhibiting NLRP3.
- Published
- 2023
- Full Text
- View/download PDF